|
|
ARIZONA HOUSE OF REPRESENTATIVESFifty-sixth Legislature First Regular Session |
Senate: HHS DP 7-0-0-0 | 3rd Read 24-5-1-0
|
SB 1254: opioids; containers; labeling; requirements; repeal
Sponsor: Senator Shamp, LD 29
House Engrossed
Overview
Allows prescription opioid containers that contain a schedule II-controlled substance to have a red cap but must have a warning label prescribed by the Arizona State Board of Pharmacy (Board) about potential addiction.
History
Laws 2018, First Special Session, Chapter 1 outlines requirements for prescribing, administering using and dispensing controlled substances. Specifically, it requires containers of schedule II opioids that are dispensed directly by a pharmacist and not for immediate use to have a red cap and a warning label prescribed by the Board about potential addiction.
The U.S. Drug Enforcement Administration (DEA) describes schedule II drugs, substances or chemicals as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. Some examples of schedule II drugs are: cocaine, methamphetamine, Adderall and oxycodone (DEA).
Provisions
1.
Allows containers of a schedule
II-controlled substance that is an opioid and directly dispensed by a
pharmacist and not for immediate administration to the ultimate user to have a
red cap but must have a warning label prescribed by the Board about potential
addiction.
2. Removes the ability of the Board or its Executive Director, if delegated by the Board, to waive the red cap requirement if implementation is not feasible because of the specific dosage form or packaging type. (Sec. 1)
3. Makes technical changes. (Sec. 1)
----------
DOCUMENT FOOTER ---------
SB
1254
Initials AG Page 0 House
Engrossed
----------
DOCUMENT FOOTER ---------